-
Argus Cites Cardinal Health's Margin Improvements In Upgrade
Monday, April 2, 2018 - 1:52pm | 372Read More...Cardinal Health Inc (NYSE: CAH) showed an improvement in gross margin in its fiscal second-quarter earnings report, and investors should have confidence in the company's ability to drive even more expansion, according to Argus. The Analyst Argus' David Toung upgraded...
-
Analyst: Buy CRH Medical After An 'Overdone' Selloff
Monday, July 17, 2017 - 11:40am | 361Read More...CRH Medical Corp (NYSE: CRHM)'s 27 percent plunge on Friday in reaction to rate changes by the Medicare & Medicaid Services (CMS) is overdone and investors should consider buying shares on the weakness, Cannacord Genuity's Richard Close said in a report. The proposed changes by the CMS...
-
Guidance Monday: 5 Companies Issue Preliminary Guidance
Monday, January 9, 2017 - 11:21am | 522Read More...Investors and traders are waking up to the first full trading week of 2017 with a handful of companies issuing preliminary guidance. Given the wide range of market capitalization sizes and completely different industries the companies operate in, it would be difficult to make the case for any macro...
-
Exclusive: Cytosorbents CEO On How Its Blood Purification Technology Can Change Healthcare
Monday, August 15, 2016 - 8:54am | 611Read More...Cytosorbents Corp (NASDAQ: CTSO) is a critical care focused immunotherapy company that focuses on the commercializing its main product, CytoSorb - a blood purification technology which focuses on preventing or treating multiple organ failures. Benzinga had the opportunity to chat with the...
-
Walgreens' Relationship With Theranos 'An Extreme Case Study Of What Can Go Wrong'
Thursday, May 26, 2016 - 11:58am | 317Read More...Business textbooks looking to include a chapter on a deal gone bad should take a closer look at Walgreens Boots Alliance Inc (NASDAQ: WBA)'s partnership with Theranos Inc. Theranos is a startup company whose testing devices called Edison examine blood samples to identify dozens of conditions. What...
-
ConforMIS Tanks 40% Following Slashed Guidance
Friday, May 13, 2016 - 8:55am | 236Read More...Shares of ConforMIS Inc (NASDAQ: CFMS), a medical technology company that is engaged in joint replacement implants, were trading lower by nearly 40 percent early Friday morning. ConforMIS reported first quarter results after Thursday's market close and provided second quarter guidance....
-
St. Jude Soars 30% After Abbott Announces $25 Billion Acquisition
Thursday, April 28, 2016 - 7:38am | 398Read More...Shares of St. Jude Medical, Inc. (NYSE: STJ) soared higher by nearly 30 percent Thursday morning after Abbott Laboratories (NYSE: ABT) announced it has entered into an agreement to acquire the medical device manufacturer. As part of the agreement, Abbott will acquire St. Jude for a total...
-
Examworks Group Announces It Will Sell Itself To A PE Firm For $35.05 A Share
Wednesday, April 27, 2016 - 10:35am | 337Read More...Examworks Group, Inc. (NYSE: EXAM), a provider of independent medical examinations, peer reviews, bill reviews, Medicare compliance and other related services, announced on Wednesday it has agreed to sell itself to an affiliate of Leonard Green & Partners, L.P., a private equity firm. As...
-
Rockwell Medical Is Getting Killed Because Of These Numbers
Tuesday, March 1, 2016 - 10:31am | 257Read More...Shares of Rockwell Medical Inc (NASDAQ: RMTI) were trading lower by more than 35 percent ahead of Tuesday's market open. Rockwell Medical said that it lost $0.12 per share in the fourth quarter on revenue of $14.1 million – short of the $0.02 per share Wall Street analysts expected the...
-
Toshiba Looking To Sell Its Medical Unit, Expected To Receive 'Aggressive Bids'
Monday, February 29, 2016 - 9:09am | 154Read More...According to Reuters, Toshiba Corp is looking to sell its entire medical equipment unit that could be valued at more than $3.5 billion. Reuters, citing "people familiar with the sale process," stated that "aggressive bidding" could place a price tag of up to $4.4 billion for...
-
St. Jude Medical Received FDA Approval For MultiPoint Pacing Technology
Wednesday, February 17, 2016 - 2:02pm | 281Read More...Correction: An earlier version of this article's title stated the covered material was related to St. Jude Medical's FDA approval for treatment of chronic intractable pain of the limbs. This version has been updated. More information on St. Jude's other release is here. Shares of St...
